DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 913 filers reported holding DANAHER CORPORATION in Q2 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,020,524 | +0.9% | 8,144 | -2.4% | 0.08% | -2.5% |
| Q2 2023 | $2,002,446 | -2.6% | 8,344 | +2.3% | 0.08% | -3.6% |
| Q1 2023 | $2,055,134 | +20.1% | 8,154 | +26.4% | 0.08% | +18.6% |
| Q4 2022 | $1,711,693 | +82.3% | 6,449 | +77.2% | 0.07% | +70.7% |
| Q3 2022 | $939,000 | -8.0% | 3,639 | -9.7% | 0.04% | -8.9% |
| Q2 2022 | $1,021,000 | -15.3% | 4,028 | -1.9% | 0.04% | -10.0% |
| Q1 2022 | $1,205,000 | +24.9% | 4,107 | +40.0% | 0.05% | +22.0% |
| Q4 2021 | $965,000 | +9.0% | 2,934 | +0.9% | 0.04% | 0.0% |
| Q3 2021 | $885,000 | +110.7% | 2,907 | +85.6% | 0.04% | +115.8% |
| Q2 2021 | $420,000 | +9.1% | 1,566 | -8.4% | 0.02% | +5.6% |
| Q1 2021 | $385,000 | +1.3% | 1,710 | 0.0% | 0.02% | -10.0% |
| Q4 2020 | $380,000 | +3.3% | 1,710 | 0.0% | 0.02% | -13.0% |
| Q3 2020 | $368,000 | +21.5% | 1,710 | 0.0% | 0.02% | +27.8% |
| Q2 2020 | $303,000 | -56.5% | 1,710 | -66.1% | 0.02% | -66.0% |
| Q1 2020 | $697,000 | -9.8% | 5,040 | 0.0% | 0.05% | +32.5% |
| Q4 2019 | $773,000 | +6.2% | 5,040 | 0.0% | 0.04% | +5.3% |
| Q3 2019 | $728,000 | +1.1% | 5,040 | 0.0% | 0.04% | -2.6% |
| Q2 2019 | $720,000 | +8.3% | 5,040 | 0.0% | 0.04% | +8.3% |
| Q1 2019 | $665,000 | +28.1% | 5,040 | 0.0% | 0.04% | +24.1% |
| Q4 2018 | $519,000 | -5.3% | 5,040 | 0.0% | 0.03% | +16.0% |
| Q3 2018 | $548,000 | +10.3% | 5,040 | 0.0% | 0.02% | +4.2% |
| Q2 2018 | $497,000 | +0.8% | 5,040 | 0.0% | 0.02% | -7.7% |
| Q1 2018 | $493,000 | +5.3% | 5,040 | 0.0% | 0.03% | +8.3% |
| Q4 2017 | $468,000 | +8.1% | 5,040 | 0.0% | 0.02% | -11.1% |
| Q3 2017 | $433,000 | +1.9% | 5,040 | 0.0% | 0.03% | -6.9% |
| Q2 2017 | $425,000 | -1.4% | 5,040 | 0.0% | 0.03% | +11.5% |
| Q1 2017 | $431,000 | +9.9% | 5,040 | 0.0% | 0.03% | +8.3% |
| Q4 2016 | $392,000 | -12.1% | 5,040 | -11.4% | 0.02% | -27.3% |
| Q3 2016 | $446,000 | +2.5% | 5,690 | 0.0% | 0.03% | +10.0% |
| Q2 2016 | $435,000 | -19.4% | 5,690 | 0.0% | 0.03% | -11.8% |
| Q1 2016 | $540,000 | +2.1% | 5,690 | 0.0% | 0.03% | +6.2% |
| Q4 2015 | $529,000 | +9.1% | 5,690 | 0.0% | 0.03% | +14.3% |
| Q3 2015 | $485,000 | +119.5% | 5,690 | +95.5% | 0.03% | +115.4% |
| Q3 2014 | $221,000 | +3.8% | 2,910 | +7.4% | 0.01% | 0.0% |
| Q2 2014 | $213,000 | +4.9% | 2,710 | 0.0% | 0.01% | +8.3% |
| Q1 2014 | $203,000 | -2.9% | 2,710 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $209,000 | – | 2,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |